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Abstract. 
 
We have cloned and characterized Xlrbpa, a 
double-stranded RNA-binding protein from 
 
Xenopus 
laevis.
 
 Xlrbpa is a protein of 33 kD and contains three 
tandemly arranged, double-stranded RNA-binding do-
mains (dsRBDs) that bind exclusively to double-
stranded RNA in vitro, but fail to bind either single-
stranded RNA or DNA. Sequence data and the overall 
organization of the protein suggest that Xlrbpa is the 
 
Xenopus
 
 homologue of human TAR-RNA binding pro-
tein (TRBP), a protein isolated by its ability to bind to 
human immunodeficiency virus (HIV) TAR-RNA. In 
transfection assays, TRBP has also been shown to in-
hibit the interferon-induced protein kinase PKR possibly 
by direct physical interaction. To determine the function 
of Xlrbpa and its human homologue we studied the ex-
pression and intracellular distribution of the two proteins. 
Xlrbpa is ubiquitously expressed with marked quanti-
tative differences amongst all tissues. Xlrbpa and human 
TRBP can be detected in the cytoplasm and nucleus by 
immunofluorescence staining and Western blotting.
Sedimentation gradient analyses and immunopre-
cipitation experiments suggest an association of cyto-
plasmic Xlrbpa with ribosomes. In contrast, a control 
construct containing two dsRBDs fails to associate with 
ribosomes in microinjected 
 
Xenopus
 
 oocytes. Nuclear 
staining of 
 
Xenopus
 
 lampbrush chromosome prep-
arations showed the association of the protein with 
nucleoli, again indicating an association of the pro-
tein with ribosomal RNAs. Additionally, Xlrbpa could 
be located on lampbrush chromosomes and in snur-
posomes. Immunoprecipitations of nuclear extracts 
demonstrated the presence of the protein in hetero-
geneous nuclear (hn) RNP particles, but not in small 
nuclear RNPs, explaining the chromosomal localization 
of the protein. It thus appears that Xlrbpa is a general 
double-stranded RNA-binding protein which is asso-
ciated with the majority of cellular RNAs, ribosomal 
RNAs, and hnRNAs either alone or as part of an 
hnRNP complex.
 
M
 
ost
 
 cellular RNAs associate with a variety of
proteins that are required for several important
cellular functions. Heterogeneous nuclear (hn)
RNP
 
1
 
 proteins, for instance, package newly transcribed
hnRNA into hnRNP particles (Piñol-Roma et al., 1988).
Splicing factors, in combination with splicing small nuclear
(sn) RNPs, on the other hand, mediate the removal of in-
trons from pre-mRNAs (reviewed by Nilsen, 1994). Other
modifying proteins are required for capping, polyadenyla-
tion, or editing of mRNA (Adam et al., 1986; Christofori
and Keller, 1989; Hamm and Mattaj, 1990; Wahle, 1991;
Bass, 1993; Polson and Bass, 1994).
Structural RNAs such as ribosomal RNAs or snRNAs
also have to be processed, modified, and complexed with
proteins to become functionally active (Reddy and Bush,
1988; Tyc and Steitz, 1989; Savino and Gerbi, 1990; Wool
et al., 1990; Peculis and Steitz, 1993; Mougey et al., 1993).
RNA-binding proteins can even be involved in the con-
trol of gene expression, such as the iron regulatory factor
that controls the stability of human transferrin receptor
mRNA and the translatability of ferritin mRNA by bind-
ing to these RNAs (Leibold and Munro, 1988; Müllner et
al., 1989). Other RNA-binding proteins are required for
the proper localization of certain RNAs thereby control-
ling cell polarity or body axis and pattern formation during
development (for review see St Johnston, 1995).
Some RNA-interacting proteins bind RNA directly while
others contact RNA only as part of a larger complex
(Piñol-Roma et al., 1988). RNA–protein interaction is fre-
quently mediated through specific RNA-binding domains
(RBDs). These domains can be quite similar to each other
in very different proteins, both in their primary amino acid
sequence and at the structural level, and can thus be de-
fined by specific consensus sequences. So far, several con-
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Abbreviations used in this paper
 
: ds, double-stranded; GST, glutathione-
S-transferase; GV, germinal vesicle; HIV, human immunodeficiency virus;
hn, heterogeneous nuclear; NLS, nuclear localization signal; polyA, poly-
adenylation; RBD, RNA-binding domain; sn, small nuclear; TAR, trans-
activation–responsive; TRBP, TAR-RNA binding protein.
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served RBDs could be defined by their homologies to each
other. Among these, the 90–100-amino acid RNA recogni-
tion motif is the most abundant and probably best-charac-
terized RBD (Bandziulis et al., 1989; Nagai et al., 1990; Wit-
tekind et al., 1992). Other well-characterized RBDs include
the zinc-finger motif, the arginine-rich motif, the RGG box,
and the KH box (for review see Burd and Dreyfuss, 1994).
A new RNA-binding motif that binds exclusively to
double-stranded RNA or RNA–DNA hybrids is the so-
called double-stranded RNA-binding domain (dsRBD) (St
Johnston et al., 1992; Green and Mathews, 1992; Bass et al.,
1994). This protein domain is 
 
z
 
70 amino acids in length
with several basic amino acids clustered at its carboxy ter-
minus. While most dsRBDs fit a consensus sequence quite
well over their entire length, some dsRBDs appear less
conserved at their amino terminus than at their basic car-
boxy-terminal end (St Johnston et al., 1992; Krovat and
Jantsch, 1996). Like other RBDs, the dsRBD can some-
times be found in multiple copies within a single protein.
So far, dsRBDs could be identified in almost 30 putative
or known RNA-binding proteins from 
 
Escherichia coli
 
to man (Kharrat et al., 1995; Krovat and Jantsch, 1996).
Recently the in-solution structure of two different dsRBDs
have been determined by nuclear magnetic resonance
(NMR) analysis (Bycroft et al., 1995; Kharrat et al., 1995).
Both studies determined virtually identical structures for
both dsRBDs, suggesting a conserved structural organiza-
tion of all dsRBDs. While some dsRBD containing proteins
associate only with specific RNAs in vivo, no sequence
specific binding of dsRBDs could so far be demonstrated
in vitro.
From a screen for RNA-binding proteins we have iso-
lated at least four different dsRBD-containing proteins
from a 
 
Xenopus
 
 ovary-specific cDNA library. One of these
proteins, named 
 
Xenopus laevis
 
 RNA-binding protein A
(Xlrbpa), shows significant homology to human trans-acti-
vation–responsive (TAR)–RNA binding protein (TRBP)
(Gatignol et al., 1991) and seems to be its 
 
Xenopus
 
 homo-
logue. Human TRBP has been isolated by its ability to bind
human immunodeficiency virus 1 (HIV-1) TAR-RNA, and
has been postulated to be involved in the transcriptional ac-
tivation of several viral promoters (Gatignol et al., 1991).
TRBP has also been shown to act as an inhibitor of the cellu-
lar interferon-induced kinase PKR when overexpressed in
COS-1 cells (Park et al., 1994). PKR is activated by double-
stranded RNAs resulting in autophosphorylation and con-
secutive phosphorylation of translation initiation factor
eIF2
 
a
 
, which leads to inhibition of protein synthesis. Inhibi-
tion of PKR by TRBP has thus been attributed to competi-
tive binding of double-stranded RNAs by TRBP, therefore
preventing their binding to PKR and subsequent activation
of kinase activity (Park et al., 1994). A possible function of
TRBP could therefore be the complexation of structured
cellular RNAs to prevent inadvertent activation of PKR.
TRBP has also been shown to dimerize with PKR through
RNA bridges (Cosentino et al., 1995). In contrast, a recent
study demonstrates physical interaction of the two proteins
in an RNA-independent manner, suggesting a regulation of
PKR by TRBP in a more direct way (Benkirane et al., 1997).
However, association of TRBP with cellular RNAs has
not been investigated to this point. We therefore studied
the expression and cellular distribution of Xlrbpa and its
 
human homologue, TRBP, both cytologically and at the
biochemical level. We also determined the association of
these proteins with RNA. Both proteins seem ubiquitously
expressed and are localized in the cytoplasm and nucleus.
In the cytoplasm, most of these proteins seem associated
with ribosomes. Additionally, lampbrush chromosome prep-
arations of 
 
Xenopus
 
 germinal vesicles revealed the associ-
ation of Xlrbpa with nascent hnRNAs on transcribing chro-
mosome loops. Both observations, the association with
ribosomes and hnRNPs were confirmed by biochemical
experiments.
 
Materials and Methods
 
Isolation of Xlrbpa cDNA
 
Xlrbpa cDNA was isolated from a 
 
Xenopus laevis
 
 ovary cDNA library by
Northwestern screening with 
 
32
 
P-labeled U1 or U2 snRNA. The screen
was performed according to the procedure of Vinson et al. (1988), except
that 8 M urea replaced 6 M guanidine hydrochloride as the chaotropic
agent. The binding buffer contained 50 mM NaCl, 10 mM MgCl
 
2
 
, 10 mM
Hepes, pH 7.5, 0.1 mM EDTA, and 1 mM DTT. The probe was a mixture
of 
 
32
 
P-labeled transcripts produced by T7 polymerase from cloned U1 and
U2 snRNA genes. The Xlrbpa insert was sequenced after conversion of
the 
 
l
 
ZAP bacteriophage into the corresponding pBluescript phagemid
(Stratagene, LaJolla, CA). These sequence data are available from
EMBL/GenBank/DDBJ under accession No. M96370.
 
Antibody Production
 
A BamHI fragment encoding the carboxy-terminal two thirds of the
Xlrbpa cDNA was cloned into the GST fusion vector pGEX (Pharmacia
Diagnostics AB, Uppsala, Sweden). Plasmids containing the proper insert
were transformed into 
 
Escherichia coli
 
 BL21. 3 ml starting cultures were
grown overnight and used to inoculate larger 300-ml cultures the next morn-
ing. When the cultures reached an OD
 
600
 
 of 0.7, protein production was
induced by the addition of isopropyl 
 
b
 
-
 
d
 
-thiogalactoside (IPTG) to 1 mM fi-
nal concentration. After an additional 4 h of incubation, cells were har-
vested by centrifugation and lysed by sonication in PBS, 1% Triton X-100.
Cell lysate was cleared by centrifugation and the supernatant was
loaded on a glutathione Sepharose 4B column (Pharmacia Diagnostics AB).
The column was washed extensively with PBS, 1% Triton X-100 to re-
move unbound protein. Bound glutathione-S-transferase (GST) fusion pro-
tein was eluted by washing the column with 5 mM glutathione in 50 mM
Tris-HCl, pH 8.0. Typical yields were 3–5 mg of pure protein per 500 ml
culture.
 
Peptide Coupling
 
Peptide MJ2 (CDYVKMLKDVAEELDF) was coupled to keyhole limpet
hemocyanin (KLH) by 
 
g
 
-maleimidobutyric acid 
 
N
 
-hydroxysuccinimide es-
ter cross-linking according to Harlow and Lane (1988).
 
Antibodies
 
Two rabbits (Rb3 and Rb5) were immunized with KLH-coupled peptide
MJ2 while two rabbits (Rb6 and Rb7) were immunized with GST fusion
protein by subcutaneous injections after the immunization schemes given
by Harlow and Lane (1988). 2 wk after the first booster injection, test sera
were collected from the ear vein and tested for their ability to detect the
GST fusion protein in Western blots. Since all animals had developed an-
tibodies against Xlrbpa, two further booster injections were administered
before animals were sacrificed, at which stage all blood was collected. Sera
were prepared according to Harlow and Lane (1988) and stored frozen at
 
2
 
70
 
8
 
C.
mAb 4F4 recognizes human hnRNPs C1 and C2 (Choi and Dreyfuss,
1984). Human autoimmune sera 13751 and 92751 recognize ribosomal
phosphoproteins P0, P1, and P2 as determined by comparison with refer-
ence serum SD1 obtained from CDC (Atlanta, GA) (Steiner, G., personal
communication). mAb Y12 recognizes the Sm epitope of snRNPs (Lerner
et al., 1981). 
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Western Blotting
 
Sample preparation and SDS gel electrophoresis was performed according
to standard procedures. After electrophoresis, proteins were transferred to
Immobilon–PVDF (polyvinylidenedifluoride) membranes (Millipore Corp.,
Waters Chromatography, Bedford, MA). For Western blotting, peptide
antisera were used at 1:300 dilutions while antisera against GST fusion
proteins were used at a dilution of 1:500. Bound antibodies were detected
with 
 
125
 
I-labeled protein A and autoradiographed.
 
Oocyte Sections
 
Small pieces of 
 
Xenopus
 
 ovary containing oocytes of different develop-
mental stages were quick-frozen by immersion in isopentane at 
 
2
 
180
 
8
 
C,
quickly transferred to ethanol at 
 
2
 
70
 
8
 
C, and stored for 2–3 d at that tem-
perature. Dehydrated tissue was subsequently warmed to room tempera-
ture (3 h at 
 
2
 
20
 
8
 
C, 3 h at 4
 
8
 
C, 3 h at 20
 
8
 
C), and finally embedded in his-
tosec at 65
 
8
 
C after a passage through paramylalcohol.
4-
 
m
 
m sections were cut with a glass knife on a Reichert ultramicrotome
and mounted on coated slides. Sections were deparaffinized in xylene, re-
hydrated in a descending alcohol series, and used for immunostaining af-
ter a final wash in PBS. Primary antibodies were detected with secondary,
alkaline phosphatase–labeled antibodies (Harlow and Lane, 1988).
 
Immunoprecipitation
 
For precipitation of hnRNP particles, HeLa nucleoplasm was prepared ac-
cording to Choi and Dreyfuss (1984). For precipitation of ribosomal pro-
teins, small pieces of ovary were homogenized by sonication in ribosomal
buffer D (0.1 M KCl, 5 mM MgCl
 
2
 
, 1 mM 
 
b
 
-mercaptoethanol, 0.1 mM
EDTA, and 50 mM Tris-HCl, pH 7.8) containing 0.1% deoxycholic acid,
1 mM vanadyl–ribonucleoside complex, 100 
 
m
 
g/ml PMSF, 2 
 
m
 
g aprotinin,
and 2 
 
m
 
g/ml pepstatin (Brown et al., 1974). The lysate was cleared from in-
soluble material by two rounds of centrifugation at 4
 
8
 
C in a table top cen-
trifuge and the remaining supernatant was used for immunoprecipitation.
For each immunoprecipitation 40 
 
m
 
l of serum (or preimmuneserum), 5 
 
m
 
l
of ascites fluid or 500 
 
m
 
l of mAb tissue culture supernatant were coupled
to 5 mg of protein A–Sepharose beads CL4B (Pharmacia Diagnostics AB,
Uppsala, Sweden) according to Steitz (1989). After incubation of the cou-
pled beads with the cell lysates, the beads were washed several times with
the appropriate buffer and boiled directly in 2
 
3
 
 SDS sample buffer before
analysis by Western blotting.
 
Isolation of TRBP cDNA
 
A TRBP cDNA was isolated by PCR amplification from a HeLa cDNA li-
brary using specific primers located at the 5
 
9
 
 and 3
 
9
 
 end of the open-read-
ing frame. Approximately 10
 
6
 
 plaque forming units (pfu) were directly
used in the PCR. The 5
 
9
 
 and 3
 
9
 
 primers carried BamHI and KpnI sites, re-
spectively. After amplification, the PCR product was gel purified, cut with
BamHI and KpnI, and cloned directly between the BamHI and KpnI sites
of a pBluescript KS vector.
 
Immunoprecipitation of TRBP
 
Capped TRBP mRNA was in vitro transcribed by T7 RNA polymerase
after linearization of the template with KpnI. In vitro–transcribed RNA
was checked for integrity by gel electrophoresis and used for in vitro
translation in a rabbit reticulocyte extract (Promega Corp., Madison, WI)
in the presence of 
 
35
 
S-labeled methionine. The translation product was
checked by SDS gel electrophoresis followed by autoradiography. To de-
termine whether antibodies directed against 
 
Xenopus
 
 Xlrbpa would also
recognize human TRBP, the in vitro–translated protein was used for im-
munoprecipitations with antisera Rb5, Rb6, and Rb7, coupled to protein
A–Sepharose beads. Preimmune sera or beads alone were used as a con-
trol. All immune sera were able to precipitate 
 
35
 
S-labeled human TRBP
while corresponding controls failed to do so.
 
Isolation of Ribosomes
 
Xenopus
 
 ribosomes were isolated from pieces of ovary containing 
 
z
 
100
mature oocytes. The ovaries were homogenized in ribosomal buffer D con-
taining 0.1% deoxycholic acid, 1 mM vanadyl–ribonucleoside complex,
100 
 
m
 
g/ml PMSF, 2 
 
m
 
g aprotinin, and 2 
 
m
 
g/ml pepstatin by ultrasonication
on ice. The crude extract was centrifuged twice for 15 min in a cooled ta-
ble top centrifuge. Avoiding the fatty surface layer, the supernatant was
layered over a linear 10% to 30% (wt/vol) sucrose gradient prepared in ri-
bosomal buffer E (50 mM KCl, 2 mM MgCl
 
2
 
, 1 mM 
 
b
 
-mercaptoethanol,
50 mM Tris-HCl, pH 7.8) and centrifuged for 4.5 h at 26,000 rpm in a
Beckman SW28 rotor (Beckman Instruments, Inc., Fullerton, CA) at 4
 
8
 
C
(Brown et al., 1974). Gradients were fractionated in a cold room. 1-ml
fractions were taken from the bottom of the gradient and absorbance at
254 nm was monitored with an UV M-II optical unit (Pharmacia Diagnos-
tics AB).
 
Immunofluorescence Staining
 
Cells grown on acid-etched coverslips were fixed and permeabilized accord-
ing to Fu and Maniatis (1990), with the exception that methanol replaced
acetone in the permeabilization step. After fixation, cells were dehydrated
through an ethanol series, permeabilized with methanol at 
 
2
 
20
 
8
 
C for 10
min, washed in 70% ethanol, and transferred to PBS. Lampbrush chromo-
some preparations were performed as described (Gall et al., 1991). Immu-
nofluorescence staining was performed as described by Wu et al. (1991).
 
Construction of Control Construct MP-2
 
Control construct MP-2 was constructed by PCR amplification of the two
dsRBDs of a clone related to 4f1 (Bass et al., 1994). Primers were designed
in a way to allow in-frame cloning of the amplified fragment upstream of
six myc tags, followed by the polyadenylation (polyA) tail of NO38 cDNA.
The resulting clone encodes a protein with a calculated molecular weight of
32 kD consisting of two dsRBDs followed by six COOH-terminal myc tags.
 
Protein Expression and Northwestern
RNA-binding Assay
 
To determine the RNA-binding ability of construct MP-2, the coding re-
gion of this construct was cloned in-frame into the protein expression vector
pET17b. For a comparison of RNA-binding of MP-2 and wild-type Xlrbpa,
the entire coding region of Xlrbpa was cloned into the protein expression
vector pET 3b, resulting in construct pET3.5. For protein expression, both
clones were transformed into 
 
E. coli
 
 BL21(DE3). Small cultures were
grown to mid log phase at which stage protein expression was induced by
the addition of 1 mM isopropyl 
 
b
 
-
 
d
 
-thiogalactoside (IPTG). After 2 h of
induction, cells were harvested by centrifugation and cell lysates were pre-
pared by sonication in SDS sample buffer. RNA-binding assays were per-
formed as described, using radiolabeled poly rI/rC as a double-stranded
RNA substrate (St Johnston et al., 1992).
 
Multimerization Assay
 
To determine a possible multimerization of Xlrbpa, the full-length protein
was expressed from construct pET3.5 (see above) in 
 
E. coli
 
 BL21(DE3).
Overexpressed protein was purified by two rounds of cation-exchange
chromatography resulting in at least 90% pure protein as judged by SDS
gel electrophoresis. Purified Xlrbpa was RNA-binding as determined by
Northwestern assay.
The multimerization potential of Xlrbpa was tested by chromatography
of purified protein on a Sepharose CL-4B sizing column (Pharmacia Diag-
nostics AB) next to suitable sizing standards. On these columns Xlrbpa
eluted right at its calculated molecular weight of 32 kD, giving no indica-
tion for a potential multimerization of the protein. As a second approach
to determine potential multimerization of Xlrbpa in solution, glutaralde-
hyde cross-linking of the protein was performed (Thompson et al., 1991).
Transcription factor GCN-4 and carbonic anhydrase were used as positive
and negative controls in the same assay. Cross-linking products were ana-
lyzed by SDS electrophoresis and silver staining of gels. No cross-linking
of Xlrbpa could be detected in this assay. Finally, purified Xlrbpa was sub-
jected to sedimentation gradient analysis. Again, there was no indication
for a possible multimerization of Xlrbpa, as the protein always migrated at
the top of the gradient.
 
Tissue Culture Transfection Assays
 
To determine the cellular localization of construct MP-2, the coding re-
gion, including the six myc tags and the polyA tail of MP2 were cloned
into the eukaryotic expression vector pcDNA (Invitrogen, San Diego, CA).
The resulting construct was used for transient transfection of coverslip-
grown HeLa cells. Immunofluorescence staining of transfected cells was
performed as described (Jantsch and Gall, 1992). 
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Oocyte Injection
 
Construct MP-2 was linearized at a unique BamHI site downstream of the
NO38 polyA tail. Capped in vitro–transcribed RNA was produced using
T3 RNA polymerase as described (Jantsch and Gall, 1992). Oocytes were
injected with 
 
z
 
50 ng RNA per oocyte and incubated overnight at 16
 
8
 
C to
allow protein synthesis. For Western blotting, 
 
z
 
10 germinal vesicles (GV)
or three cytoplasms were used, per lane. For sedimentation gradient anal-
ysis, the homogenate of 
 
z
 
100 microinjected oocytes were used for each
gradient. The MP-2 myc fusion protein was detected by Western blotting
using mAb 9E10 directed against the myc tag, and a secondary anti–
mouse antibody labeled with alkaline phosphatase for enzymatic detec-
tion (Evan et al., 1985).
 
Results
 
Isolation of Xlrbpa cDNA
 
By Northwestern screening of a 
 
Xenopus laevis
 
 oocyte
cDNA library with radiolabeled U1 and U2 snRNAs we
have previously isolated several clones that encode pro-
teins which bind to these RNAs. Sequence analysis and
deletion mapping of the RNA-binding region within these
clones led to the identification of the dsRBD in several
cDNAs (St Johnston et al., 1992).
One group of the isolated cDNAs encodes a protein
showing strong homology to human TRBP (Gatignol et al.,
1991), both at the primary amino acid level and in its over-
all organization (Fig. 1). We called the protein encoded by
these cDNAs 
 
Xenopus laevis
 
 RNA-binding protein A
(Xlrbpa).
At the amino acid level Xlrbpa shows 
 
.
 
70% homology
and 
 
.
 
55% identity to human TRBP. The two proteins are
of similar size with calculated molecular weights of 32.8 and
36.9 kD for Xlrbpa and human TRBP, respectively. Addi-
tionally, both proteins are very similar in their general or-
ganization. Both contain three tandemly arranged dsRBDs,
each separated by short spacers of variable length (Fig. 1).
In both proteins, the third dsRBD shares a lower degree of
homology with the overall dsRBD consensus sequence while
the first and second dsRBDs are highly homologous to it
(St Johnston et al., 1992; Krovat and Jantsch, 1996).
Taken together, the data suggest that Xlrbpa is the 
 
Xen-
opus
 
 homologue of human TRBP. This view is supported
by two additional facts. First, in pairwise alignments of 20
dsRBDs from different proteins, the corresponding dsRBDs
in Xlrbpa and human TRBP always turn out to be more
closely related to each other than to any other dsRBDs in
the entire alignment (St Johnston et al., 1992; Krovat and
Jantsch, 1996). Second, antibodies directed against Xlrbpa
recognize in vitro–translated human TRBP and a protein
of identical molecular weight to TRBP in HeLa cells (see
below).
 
Expression of Xlrbpa
 
To study the distribution of Xlrbpa both at the level of the
entire organism and at the cellular level, we produced anti-
bodies against an Xlrbpa fusion protein and a peptide lo-
cated in the third dsRBD of Xlrbpa. All antisera recog-
nized Xlrbpa expressed from 
 
E. coli
 
 and the endogenous
protein in 
 
Xenopus
 
 oocytes; however, the antisera directed
against the fusion protein (Rb6 and Rb7) gave stronger
signals than peptide sera and were thus used for most parts
of this study.
On Western blots, all antisera recognized a single band
of 33 kD both in oocytes and XlA6, a 
 
Xenopus
 
 cell line
(Fig. 2 
 
a
 
), while preimmune sera showed no signals on
these blots (data not shown). The observed band of 33 kD
corresponds well with a calculated molecular weight of
32.8 kD for Xlrbpa. In addition, we tested whether any of
our antisera would recognize human TRBP, the putative
homologue of Xlrbpa. All antisera directed against Xlrbpa
fusion protein (Rb6 and Rb7) were able to specifically
immunoprecipitate 
 
35
 
S-labeled, in vitro–translated human
TRBP while the corresponding preimmune sera failed to do
so (data not shown). Additionally, antisera were tested on
Western blots for their ability to recognize human TRBP
in HeLa cell extracts. Of all sera tested, Rb6 directed
against the Xlrbpa fusion protein gave the strongest signal
on these blots. The band observed in HeLa extracts mi-
grates a little slower than the corresponding protein in
 
Xenopus
 
 oocyte extracts (Fig. 2 
 
b
 
), which is in good agree-
ment with the slightly larger molecular weight of 36 kD of
human TRBP. The corresponding preimmune serum showed
no signal in HeLa cells (data not shown). Also, the antise-
rum could be blocked by preincubation with 
 
E. coli
 
–pro-
duced Xlrbpa, suggesting that serum Rb6 recognizes au-
thentic human TRBP in HeLa cells (data not shown).
To determine the expression of Xlrbpa in adult 
 
Xenopus
 
we performed Western blots of various tissues. Xlrbpa
could be detected in all tissues investigated, including oo-
cyte, spleen, liver, kidney, heart, nerve, brain, and XlA6,
indicating that Xlrbpa is a ubiquitously expressed protein
Figure 1. Protein sequence of Xlrbpa (top) aligned with that of
human TRBP (bottom). The alignment was generated with pro-
gram “Gap” of the GCG package (GCG, Madison, WI). |, identical
amino acids; :, similar amino acids. Double-stranded RNA-binding
regions are boxed. dsRBD-1 (light gray); dsRBD-2 (dark gray);
dsRBD-3 (open box). 
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(Fig. 2, 
 
a
 
 and 
 
c
 
). There was, however, a marked quantita-
tive difference of Xlrbpa among these tissues. The protein
seemed most abundant in oocytes and liver, while only smal-
ler amounts could be detected in spleen, kidney, and heart.
In nervous tissue Xlrbpa was only barely detectable. Be-
sides full-length Xlrbpa, smaller bands were detectable in
some tissues. The occurrence and intensity of these addi-
tional bands varied with experiments and depended on the
speed of preparation, source of organs, and use of pro-
tease inhibitors. We therefore believe that these additional
bands of exclusively lower molecular weight than Xlrbpa
represent breakdown products of Xlrbpa. It should be
noted, however, that it was almost impossible to obtain
protein extracts completely free of degradation products,
indicating that Xlrbpa is very sensitive to proteolytic deg-
radation.
 
Intracellular localization of Xlrbpa
 
Human TRBP has been suggested to be involved in the
transcriptional activation of HIV TAR-RNA and also has
been shown to increase the expression of reporter genes
when expressed under the control of other viral promoters
(Gatignol et al., 1991). However, an RNA-independent in-
teraction of TRBP with the double-stranded RNA-activated
kinase PKR has also been reported recently (Benkirane
et al., 1997). Direct transcriptional activation could only take
place in the nucleus while interaction of TRBP with the
cytoplasmic kinase PKR would most likely occur in the cy-
toplasm. We therefore wanted to determine the intracellu-
lar localization of Xlrbpa and its human homologue TRBP.
To do this, immunostainings of oocyte sections and cover-
slip-grown HeLa tissue culture cells were performed. Ad-
ditionally, we made Western blots of hand-enucleated oo-
cytes and isolated germinal vesicles.
Surprisingly, most of the protein could be detected in
the cytoplasm of stained oocyte sections (Fig. 3). Upon close
investigation, however, minor staining could also be de-
tected in the nucleus where staining appeared in small
dots, possibly representing nucleoli or chromatin. The
same result was obtained on Western blots of hand-iso-
lated GVs and enucleated oocytes (Fig. 2 
 
d
 
).
For comparison, we stained coverslip-grown HeLa tis-
sue culture cells with the anti-Xlrbpa antiserum Rb6. As
mentioned, this antiserum recognizes human TRBP (Fig.
2 
 
b
 
). Similar to the situation in oocytes, human TRBP in
HeLa cells seemed to be located in both the cytoplasm and
the nucleus, resulting in an almost homogeneous staining
pattern (Fig. 4). However, when compared to oocytes, the
concentration of TRBP in HeLa cells seemed relatively high
in the nucleus. In the cytoplasm, the staining appeared in
minute dots possibly colocalized with the ER. Colocalization
of TRBP with the ER could be indicative of an association
of the protein with ribosomes. Therefore, to compare the
cytoplasmic distribution of TRBP with that of ribosomes
in HeLa cells we performed double immunofluorescence
staining with Rb 6 and serum 13751, an anti-ribosomal au-
toimmune serum that recognizes ribosomal proteins P0,
P1, and P2 (Steiner, G., unpublished results), which are
the putative eukaryotic homologues of bacterial ribosomal
proteins L10, L7, and L12, respectively (Santos and Bal-
lesta, 1994). In these experiments both sera showed similar
staining patterns, consistent with an association of TRBP
with the ER (Fig. 4 
 
g
 
).
Xlrbpa in Ribosomes
To determine whether the cytoplasmic localization of
Xlrbpa and its human homologue TRBP could be due to a
physical association of these proteins with ribosomes, we
performed sedimentation gradient analyses of Xenopus
oocyte extracts. In sucrose gradients, the majority of
Xlrbpa cosedimented with the peak of 80S ribosomes.
Only minor amounts could be found in the pellet and su-
pernatant corresponding to polysomes and hnRNAs, as
Figure 2. Distribution of Xlrbpa and TRBP in various frog tis-
sues and HeLa cells. (a) Equal amounts of protein extract from
Xenopus oocytes (Oo) and XlA6 tissue culture cells (XLA) were
run on a SDS gel, blotted onto Immobilon membrane and de-
tected with anti-Xlrbpa antiserum Rb6. In both tissues, a single
band of 33 kD is detectable. (b) Detection of putative human
TRBP by polyclonal serum Rb6. Oocyte extracts (Oo) and HeLa
tissue culture cell extracts (HeLa) were probed by Western blot-
ting with polyclonal serum Rb6. Antiserum Rb6 detects Xlrbpa
in Xenopus oocytes and a band of slightly larger molecular weight
in HeLa cells representing the putative homologue, human TRBP.
(c) Distribution of Xlrbpa in various frog tissues. Equal amounts
of protein from spleen, liver, kidney, heart, nerve, and brain were
probed for the presence of Xlrbpa by Western blotting with se-
rum Rb6. Xlrbpa can be detected in all tissues but in different
concentrations. Spleen and liver have the highest, heart and kid-
ney intermediate, and nerve and brain lowest concentration of
Xlrbpa. In some tissues (liver, kidney) prominent degradation
products are visible. The exposure time for nerve and brain lanes
was twice that of the other tissues. (d) Intracellular distribution of
Xlrbpa. A single enucleated oocyte (Cytoplasm) and 20 isolated
nuclei (GV) were separated on an SDS gel and probed by West-
ern blotting with serum Rb6. About equal amounts of Xlrbpa can
be detected in both lanes. Since a GV occupies ,10% of the total
oocyte volume, the proteins in the cytoplasmic lanes are derived
from half the volume than in the GV lanes. The concentration of
Xlrbpa in the nucleus is, therefore, about half of that in the cyto-
plasm. Arrows indicate position of Xlrbpa in all gels.The Journal of Cell Biology, Volume 138, 1997 244
well as free protein, respectively (Fig. 5 A). To confirm
these results and to exclude the possibility that Xlrbpa was
only trapped in the ribosomal fraction, the peaks of 80S ri-
bosomes from several gradients were concentrated by mi-
crofiltration and rerun on a second sucrose gradient. Again,
the majority of Xlrbpa was cosedimenting with 80S ribo-
somes, confirming the association of Xlrbpa with ribo-
somes (Fig. 5 A, right). A ribosomal association of Xlrbpa
is in agreement with our recent study which demonstrated
binding of Xlrbpa to rRNA in vitro (Krovat and Jantsch,
1996). The observed association of Xlrbpa with 80S ribo-
somes was unchanged by puromycin treatment of oocyte
extracts, but was sensitive to RNase A treatment (data not
shown). It should be noted, however, that the association
of Xlrbpa with ribosomes was sensitive to high salt washes.
When ribosomal pellets were exposed to salt concentra-
tions higher than 300 mM, a large fraction of Xlrbpa disso-
ciated from the ribosomes resulting in reduced amounts of
Xlrbpa cosedimenting with ribosomes and larger amounts
of Xlrbpa migrating as free protein at the top of the gradi-
ent (data not shown).
Xlrbpa has a molecular weight of 33 kD. The free pro-
tein should therefore be able to pass through a microfiltra-
tion membrane with a molecular weight cutoff of 50,000.
However, if Xlrbpa was part of a larger particle, such as a
ribosome, it should remain in the top chamber of the mi-
croconcentration device. We therefore tested the material
from the top and bottom chamber of the Centricon device
for the presence of Xlrbpa. As can be seen in Fig. 5 A, all
Xlrbpa remained in the top chamber during microconcen-
tration, indicating the association of Xlrbpa with a physical
particle .50 kD.
Purified full-length Xlrbpa does not form protein multi-
mers as judged by sizing columns, sedimentation gradients,
and glutaraldehyde cross-linking experiments (data not
shown). The possibility that Xlrbpa does not pass through
the microfiltration column due to the formation of protein
multimers could therefore be excluded. However, RNA-
dependent multimerization of TRBP and the dsRBD-con-
taining fragment of PKR kinase has been observed in the
yeast two-hybrid system and in vitro (Cosentino et al., 1995).
Even direct interaction of PKR and TRBP has been re-
ported recently (Benkirane et al., 1997). An association of
Xlrbpa with ribosomes could therefore be mediated by an
interaction of the protein with the ribosome-associated ki-
nase PKR.
Nonetheless, to exclude the possibility that Xlrbpa would
only stick to ribosomes in a nonspecific manner due to the
protein’s intrinsic RNA-binding ability or, alternatively,
would form multimers through a common RNA linker, we
determined whether an unrelated control construct con-
taining two dsRBDs would also associate or cosediment
with ribosomes when expressed in Xenopus oocytes. The
Xenopus 4f1 protein seemed suitable for this purpose. Xen-
opus 4f1 contains a nuclear localization signal (NLS) and
two dsRBDs, and is also very abundant in Xenopus oo-
cytes (Fig. 6 A) (Bass et al., 1994). The 4f1 protein is ho-
mologous to the human NF90 transcription factor (Kao et al.,
1994). A clone encoding an isoform of this protein was pre-
viously isolated by us (Jantsch, M., unpublished results).
Since full-length 4f1 protein contains an NLS and is z98
kD in size, we wanted to express a part of the protein en-
coding the two dsRBDs only. An z600-bp region, includ-
ing the two dsRBDs, was therefore amplified by PCR
Figure 3. Distribution of Xlrbpa in Oocyte sections. Oocyte sections were stained with Rb6 preimmune serum (a), or immune serum
Rb6 (b and c). (a) No staining can be observed in sections stained with preimmuneserum. (b) Staining with immuneserum Rb6 shows
strong cytoplasmic and also nuclear signals, indicating that most but not all of Xlrbpa is located in the cytoplasm. An arrowhead marks
the oocyte enlarged in c. (c) Enlargement of the small oocyte marked by an arrowhead in b. Besides the strong cytoplasmic signal, nu-
clear staining can also be observed. The observed nuclear signals (marked by arrows) could represent nucleoli or chromatin. Bars: (a
and b) 200 mm; (c) 20 mm.Eckmann and Jantsch Xenopus laevis Double-stranded RNA-binding Protein A 245
from our 4f1-related cDNA and cloned in-frame upstream
of six myc tags which are followed by the 39 UTR and
polyA tail of Xenopus NO38 in a pBluescript SK vector
(Fig. 6 B) (Jantsch and Gall, 1992). The resulting construct,
designated as MP2, was sequenced to confirm the pres-
ence of the coding region for the two dsRBDs and the six
myc tags (Fig. 6 C). The putative translation product of MP2
has a calculated molecular weight of z31 kD and should
thus, like Xlrbpa, be able to diffuse into the nucleus. To
determine whether MP2 was indeed able to bind dsRNA,
the MP2 myc fusion and full-length Xlrbpa were expressed
in E. coli and tested for their RNA-binding ability in a
Northwestern assay. As expected, both proteins showed
strong in vitro RNA-binding ability (Fig. 7, A and B).
For expression of MP2 in Xenopus oocytes, in vitro tran-
scripts of the construct were injected into oocytes. West-
ern blots of nuclear and cytoplasmic extracts were de-
tected with mAb 9E10 directed against the myc tag (Evan
et al., 1985). Although the protein migrated at a slightly
aberrant molecular weight of z38 kD, MP2 could be de-
tected in the cytoplasm and the nucleus, indicating that
MP2 carried no cryptic NLS but could freely diffuse into
the nucleus (Fig. 7 C).
To determine whether MP2 would associate with ribo-
somes, we performed sedimentation gradient analyses of
oocytes expressing MP2. 100 oocytes were injected with MP2
RNA. After overnight incubation, to allow protein synthe-
sis to occur, the oocytes were homogenized and loaded on
a sedimentation gradient. Fractions of these gradients were
then analyzed for the presence of MP2 protein (Fig. 5 B).
As expected, no MP2 protein could be found cosediment-
ing with ribosomes. Instead all MP2 protein remained at
the top of the gradient indicating that MP2 protein, al-
though RNA-binding, failed to form multimers or to asso-
ciate with ribosomes.
Colocalization in situ and cosedimentation of Xlrbpa with
ribosomes is indicative, but does not provide absolute proof
for the physical association of the protein with ribosomes.
Therefore, to test the association of Xlrbpa and TRBP
with ribosomes in a more direct manner, we performed
Figure 4. Localization of Xlrbpa and ribosomes in HeLa cells. Coverslip-grown HeLa cells were stained with preimmune serum Rb6 (a–
c), immune serum Rb6 (d–f), and anti-ribosomal serum 13751 (g). (a and d) Phase contrast images, (b and e) DAPI images, (c and f)
FITC images, and (g) rhodamine image. Preimmune serum Rb6 shows no signal in HeLa cells (c), while staining with immuneserum
Rb6 reveals a homogenous, slightly punctate pattern in the entire cell (f). (g) Cells in f were double-labeled with an anti-ribosomal se-
rum 13751 which was visualized in the rhodamine channel. Staining with both anti-Xlrbpa and anti-ribosomal serum 13751 resulted in
very similar images, revealing a homogeneous, slightly punctate staining pattern over the entire cell. Bar, 10 mm.The Journal of Cell Biology, Volume 138, 1997 246
coimmunoprecipitation experiments. Two different anti-
ribosomal autoimmune sera were used to precipitate ribo-
somes from oocyte extracts. The precipitated material was
then tested for the presence of Xlrbpa by Western blot-
ting. Both antisera, serum 9275 and serum 13751 were able
to coprecipitate Xlrbpa with ribosomes, while all Xlrbpa
remained in the supernatant when no antibody was added
to the beads (Fig. 8 A). In contrast, when MP2-injected oo-
cytes were used in the same experiment, no coprecipita-
tion of MP2 protein with ribosomes could be detected
(Fig. 8 B, and data not shown). These data suggest that
Xlrbpa and possibly its human homologue, TRBP, are
closely associated with ribosomes. Our control experiments
also indicate that ribosomal association of these two pro-
teins is specific and not merely an effect of the intrinsic
RNA-binding ability of any dsRBD-containing protein.
Figure 5. Sedimentation gradient analysis of Xlrbpa and control
construct MP2. (A) Oocyte lysates were fractionated on sucrose
gradients and tested for the distribution of Xlrbpa (left). UV ab-
sorbance at 260 nm was recorded for all fractions (top) indicating
the peak of 80S ribosomes in fractions 13–23. Representative frac-
tions were tested by Western blotting with serum Rb7 for the
presence of Xlrbpa (A). The majority of Xlrbpa could be found in
the ribosomal peak fractions (fractions 16 and 18). In these frac-
tions, degradation bands of lower molecular weight could also be
detected. Minor amounts of Xlrbpa could be found at the top of
the gradient (fraction 34), corresponding to free protein. How-
ever, the free protein was mostly degraded. Unfractionated oo-
cyte extract was loaded in the first two lanes (Oo). Position of
full-length Xlrbpa is indicated by an arrow. Ribosomal peaks
from several primary gradients were concentrated in a Centricon
microconcentration device (exclusion limit 5 50 kD) and rerun on
a second sucrose gradient (right). Supernatant (cen) and flow-
through (ft) from the microconcentration step was also moni-
tored for the presence of Xlrbpa. Xlrbpa was exclusively present
in the top chamber, indicating the presence of the protein in a
particle larger than 50 kD. UV absorbance of the gradient rerun
was monitored (top) and representative fractions were tested for
the presence of Xlrbpa (A). Again, the majority of Xlrbpa could
be found in the ribosomal peak fractions. No free protein could
be found in the supernatant fraction (34). (B) Oocyte lysates of
MP2-injected oocytes were fractionated on sucrose gradients.
Fractions were monitored for the presence of MP2 protein by
Western blotting with mAb 9E10 directed against the myc epi-
tope. No MP2 protein could be found in the ribosomal peak frac-
tions. Instead all MP2 remained at the top of the gradient. Un-
fractionated extracts of injected oocytes (Oo) were loaded as a
control.
Figure 6. Schematic representation of control construct MP2. (A)
Clone 4f1 contains two dsRBDs (gray boxes) and a NLS (hatched
box). PCR primers used to amplify the sequence encoding the two
dsRBDs are indicated by arrows. (B) The PCR amplified frag-
ment was cloned upstream of six tandemly arranged myc tags (open
box) and the NO38 39 UTR and poly(A)1 tail in pBluescript KS
to give construct MP2. T3 transcripts of the construct could be
made after linearization at a unique restriction site downstream
of the NO38 A1 tail. (C) Conceptual translation product of MP2.
Gray boxes, the two dsRBDs. Underlining, the myc epitopes.
Figure 7. RNA-binding abil-
ity of construct MP2 and de-
tection of the protein by myc
antibodies in oocytes. (A)
Control construct MP2 and
full-length Xlrbpa were ex-
pressed in Escherichia coli.
RNA-binding abilities of
both constructs were deter-
mined by Northwestern prob-
ing of E. coli lysates. Both
proteins show strong RNA-
binding activity. (B) Detec-
tion of epitope-tagged MP2
protein by mAb 9E10 di-
rected against the myc tag. E.
coli lysates of cells expressing
either MP2 or Xlrbpa protein
were probed by Western
blotting with mAb 9E10.
MP2 protein is readily de-
tectable by mAb 9E10. (C)
Detection of MP2 protein in
microinjected oocytes. 1 cytoplasm (Cytopl) and 10 germinal vesi-
cles (GV) of injected (MP2) and uninjected (Con) oocytes were
separated by SDS-PAGE and tested for the presence of MP2
protein by Western blotting with mAb 9E10. MP2 protein could
be detected in both cellular compartments indicating that MP2
can freely diffuse into the nucleus. No protein could be detected
in uninjected oocytes.Eckmann and Jantsch Xenopus laevis Double-stranded RNA-binding Protein A 247
Xlrbpa in the Nucleus
Xlrbpa and TRBP could not only be detected in the cyto-
plasm, but were also present in the nucleus as shown by in
situ immunostaining and Western blotting of hand-enucle-
ated oocytes and germinal vesicles. Xlrbpa does not con-
tain an obvious consensus nuclear localization signal (Ding-
wall and Laskey, 1991). Its presence in the nucleus and the
relatively small molecular weight of ,33 kD therefore
suggest that the protein can enter the nucleus by diffusion.
To investigate the nuclear localization of Xlrbpa and
TRBP in more detail we performed immunofluorescence
stainings of spread Xenopus germinal vesicles. Because of
its size, the amphibian germinal vesicle allows a detailed
observation of nuclear organelles like lampbrush chromo-
somes, amplified nucleoli and snurposomes, spherical or-
ganelles enriched in snRNPs, and several accessory splic-
ing factors (Wu et al., 1991). Nascent transcripts on the
chromosomes can easily be detected as well as pre-riboso-
mal RNAs on nucleoli.
In these spreads Xlrbpa was detectable in essentially all
RNA-containing structures; nucleoli, lampbrush chromo-
somes, and snurposomes showed moderate to strong stain-
ing with anti-Xlrbpa antibodies, indicating the association
of the protein with most, if not all nuclear RNAs. This
general picture was independent of the antibody used for
immunofluorescence staining (Fig. 9).
The staining on the amplified nucleoli suggests that ri-
bosomal transcripts already associate with Xlrbpa before
their export from the nucleus and assembly into mature ri-
bosomes. This observation is in good agreement with our
finding that Xlrbpa is present in ribosomes. Xlrbpa is a
double-stranded RNA-binding protein; ribosomal RNAs
are known to contain long, double-stranded stem-loop re-
gions and hairpins (Noller et al., 1981), and could thus pro-
vide enough binding sites for Xlrbpa.
In addition to nucleoli, the RNP matrix of lampbrush
chromosomes stained homogeneously along the length of
the entire chromosome. This was somewhat surprising since
it seemed unlikely that all transcripts contain sufficient
double-stranded regions to allow binding of significant
amounts of Xlrbpa. However, the homogeneous and rela-
tively intense staining of all transcripts could be explained
if Xlrbpa associated with nascent transcripts as part of a
larger hnRNP complex (Piñol-Roma et al., 1989). In this
case, not Xlrbpa itself, but other proteins within the
hnRNP complex would make the contact with RNA where
Xlrbpa would only bind directly to RNA if sufficient dou-
ble-stranded regions were present. To test this hypothesis,
we wanted to determine whether Xlrbpa was associated
with hnRNP particles. We therefore made immunoprecip-
itations with anti-Xlrbpa antibodies and tested the precipi-
tated material for the presence of known hnRNPs. As a
precipitating antibody we used antisera Rb6 or Rb7 and
the corresponding preimmune sera as controls. Both anti-
sera are able to precipitate in vitro–translated human
TRBP (data not shown) and recognize human TRBP on
Western blots (Fig. 2 b). For the detection of hnRNP pro-
teins we used mAb 4F4 directed against human hnRNPs
C1 and C2 (Choi and Dreyfuss, 1984). Since mAb 4F4 only
recognizes human hnRNPs, and not the corresponding
proteins from Xenopus, we used HeLa nucleoplasmic ex-
tracts as starting material. Both antisera Rb 6 (Fig. 10 A) and
Rb 7 (not shown) were able to coprecipitate hnRNPs C1
and C2 very efficiently while no signals were seen when ei-
ther preimmuneserum was used. Coprecipitation of hnRNPs
C1 and C2 by anti-Xlrbpa antisera was resistant to predi-
gestion of the nucleoplasmic extracts with RNases, indicat-
ing a physical association of Xlrbpa with these hnRNPs. We
thus believe that Xlrbpa is part of hnRNP particles, which
would also explain its presence on nascent transcripts.
To determine whether the dsRBD-containing control
construct MP2 would also associate with hnRNP particles,
we performed immunoprecipitation experiments with HeLa
cells which were stably transfected with a eukaryotic vec-
tor expressing MP2 protein. Immunofluorescence staining
of these cell lines with mAb 9E10 showed a homogeneous
distribution of MP2 protein throughout the entire cell
(data not shown). Immunoprecipitations of stably express-
ing cell lines were performed with either mAb 4F4 di-
rected against hnRNPs C1 and C2, or with polyclonal serum
Rb6 directed against Xlrbpa (TRBP). Immunoprecipitates
were then probed with mAb 9E10 for the presence of myc-
tagged MP2 protein (Fig. 10 B). In these experiments,
MP2 protein could not be coprecipitated with either anti-
body, indicating that MP2 protein does not associate with
hnRNP particles.
The positive staining of snurposomes indicated the pres-
ence of Xlrbpa in these structures. Two types of snurpo-
somes (B and C) can be distinguished in Xenopus GVs.
Figure 8. Coprecipitation of Xlrbpa with ribosomal proteins. (A)
Immunoprecipitations of oocyte extracts were made with anti-
ribosomal sera 13751, 92751, or beads alone. The immunoprecipi-
tated material (p) and an aliquot of the corresponding superna-
tant (sn) were tested for the presence of Xlrbpa. Both sera 13751
and 92751 were able to coprecipitate Xlrbpa, while no protein
could be precipitated when no antibody had been added to the
beads. As a control, a small aliquot of total oocyte extract was
loaded (total). An arrow indicates position of Xlrbpa. (B) In con-
trast, MP2 protein could not be coprecipitated by either anti-
ribosomal serum. When oocytes injected with MP2 RNA were
used for the same experiment all MP2 protein remained in the su-
pernatant. An arrow indicates position of MP2 protein.The Journal of Cell Biology, Volume 138, 1997 248
The smaller B snurposomes, which can sometimes be
found associated with C snurposomes, are highly enriched
in the five splicing snRNPs, U1, U2, U5, and U4/U6 (Wu
et al., 1991). Besides these snRNPs, accessory splicing fac-
tors such as SC-35 or SR proteins can be found in these
structures (Roth et al., 1991; Zahler et al., 1992). However,
also hnRNPs can be detected in B snurposomes (Wu et al.,
1991). In contrast, no hnRNPs could so far be detected in
the generally larger C snurposomes. Instead, C snurpo-
somes seem to contain U7 snRNPs as the only snRNP
component (Wu and Gall, 1993). The presence of p80 coi-
lin in these structures suggests a homology of C snurpo-
somes and coiled bodies found in somatic cells (Wu et al.,
1994; Gall et al., 1995).
In our immunofluorescence stainings, C snurposomes
labeled generally more intensely than B snurposomes, sug-
gesting a higher concentration of Xlrbpa in the former
structures (Fig. 9). This was somewhat surprising since no
hnRNPs could so far be detected in C snurposomes. How-
ever, since all snurposomes contain snRNPs, we wanted to
determine whether the presence of Xlrbpa in snurposomes
could be due to an association of the protein with snRNPs.
We performed immunoprecipitation experiments with
anti-Xlrbpa and anti-snRNP antibodies and tested the pre-
cipitated material for the presence of snRNP proteins or
Xlrbpa, respectively. In these experiments, no association
of Xlrbpa with snRNPs could be detected (data not
shown). It thus seems unlikely that Xlrbpa is associated
with snRNAs in snurposomes. Instead, Xlrbpa could be
associated with other hnRNPs, at least in B snurposomes.
Discussion
We have cloned and characterized Xlrbpa, a Xenopus
double-stranded RNA-binding, 33-kD protein. Our data
indicate that Xlrbpa is the putative homologue of human
TRBP (Gatignol et al., 1991). Both proteins show a high
degree of homology at the primary amino acid level and in
their overall organization. They contain three tandemly
arranged dsRBDs. In both proteins, the first two dsRBDs
show a high degree of homology to a dsRBD consensus se-
quence while the third dsRBD fits the consensus only at its
carboxy-terminal end (St Johnston et al., 1992). The
dsRBD has been shown to exclusively interact with dou-
ble-stranded RNAs or RNA–DNA hybrids (St Johnston
et al., 1992; Bass et al., 1994). A preference for these two
substrates could be explained by the similar structures ex-
hibited by these double-stranded molecules; both RNA–
DNA and RNA–RNA helices assume A form helices,
which differ considerably from the B form helices adopted
Figure 9. Localization of Xlrbpa in nuclear spreads of Xenopus GVs. (a and b) Lampbrush chromosome preparations were stained with
preimmune serum Rb6 or (c and d) immune serum Rb6. Antibodies were detected with a secondary FITC-labeled antibody. (a and c)
Phase contrast; (b and d) fluorescence image. (a) Lampbrush chromosomes, C snurposomes (C), B snurposomes (B), and nucleoli (N)
can be seen in the phase contrast image. The large C snurposome (C) has a smaller B snurposome attached to its surface. (b) No staining
can be observed with preimmune serum Rb6. (c) Nuclear organelles are labeled as in (a). The large C snurposome (C) has an attached
B snurposome (B). (d) Essentially all nuclear structures are labeled after staining with serum Rb6. Lampbrush chromosomes, nucleoli
(N), C snurposomes (C), and B snurposomes (B) are easily detectable. C snurposomes label most brilliantly while the other structures
show only moderate staining with this antibody. A comparison of B and C snurposome staining can easily be made on the large, in-
tensely labeled C snurposome (C) which has a moderately stained, smaller B snurposome on its surface. Bar, 10 mm.Eckmann and Jantsch Xenopus laevis Double-stranded RNA-binding Protein A 249
by most double-stranded DNAs. Although both sub-
strates, RNA–RNA and RNA–DNA duplexes have been
shown to be recognized by the dsRBD in vitro, no exam-
ple of an RNA–DNA hybrid substrate has been shown to
be the natural substrate for any known dsRBD-containing
protein. In contrast, in all cases where the substrate for a
dsRBD containing protein has been identified, it repre-
sents an RNA duplex molecule. Consistent with this idea,
we could demonstrate that Xlrbpa and human TRBP are
associated with ribosomes and hnRNAs. In both cases
RNA–RNA hybrids rather than RNA–DNA hybrids seem
the likely substrates of these proteins.
Xlrbpa, a Ribosomal Protein?
Xlrbpa is ubiquitously expressed in essentially all tissues
tested and it seems likely that human TRBP is also ubiqui-
tously expressed in humans (Gatignol et al., 1991). How-
ever, we observed marked differences among the tissues
tested. Especially nerve and brain tissue showed a very
low level of Xlrbpa, while oocytes had the highest concen-
trations. These differences in concentration could possibly
be explained by our finding that Xlrbpa and TRBP associ-
ate with ribosomes. It is known that amphibian oocytes
contain extremely high levels of ribosomes. In contrast, al-
though neurons contain considerable amounts of ribo-
somes, nervous tissue as a whole has a relatively low
ribosome content. Thus, it appears that Xlrbpa concentra-
tion resembles the concentration of ribosomes in a given
tissue. Since ribosomal RNAs represent the majority of all
RNAs in a cell, it is also obvious that the low amounts of
Xlrbpa (or TRBP) assembled with hnRNPs do not fall
into account for this comparison.
We could demonstrate the association of Xlrbpa and
TRBP with ribosomes by immunofluorescence, cofraction-
ation on density gradients, and coimmunoprecipitation ex-
periments. Additionally, we could purify ribosomal RNAs
in immunoprecipitation experiments with anti-Xlrbpa an-
tibodies (data not shown). Sticking, and therefore non-
specific association of Xlrbpa (or human TRBP) with ribo-
somes, could be excluded by our control experiments in
which a dsRNA-binding control construct, containing
two dsRBDs failed to associate with ribosomes. Taken to-
gether, we are confident that Xlrbpa and TRBP are closely
associated with ribosomes. This finding is also supported
by our previous observation that Xlrbpa can bind rRNA in
vitro (Krovat and Jantsch, 1996). A ribosomal association
of Xlrbpa or TRBP is also consistent with the recent find-
ing that TRBP can interact with the ribosome-associated
kinase PKR (Benkirane et al., 1997). Ribosomes and their
components have been intensely studied over the last
decades. It is thus surprising that neither Xlrbpa, nor
human TRBP have been described as ribosomal pro-
teins, especially when considering their relative abundance.
However, most ribosomal preparations include a high salt
wash to remove associated proteins. dsRBDs lose their in
vitro–RNA-binding ability at salt concentrations .300 mM
(Jantsch, M., unpublished data). Consistently, we ob-
served a dissociation of Xlrbpa from ribosomes in sedi-
mentation gradients at high salt concentrations, which could
explain its absence from standard ribosomal preparations.
Thus, we believe that Xlrbpa is merely a ribosome-associ-
ated factor, but not a necessary component of translation-
ally active ribosomes.
Xlrbpa on Nascent Transcripts
Xlrbpa and human TRBP could also be found in the nu-
cleus. Although both proteins lack a clear nuclear localiza-
tion signal, they seem small enough to enter the nucleus by
simple diffusion through nuclear pores. In nuclear spreads
of Xenopus GVs, we could localize the protein in essen-
tially all RNA-containing structures: amplified nucleoli,
Figure 10. Association of Xlrbpa with hnRNPs. (A) HeLa nuclear
extracts were used for immunoprecipitations with anti-Xlrbpa
serum Rb6 (#6), or the corresponding preimmuneserum (PI #6).
Some of the material was digested with RNases (1RNAse) or
left undigested (2RNAse) before incubation with the antibody-
coupled beads. Before washing, the beads were pelleted by cen-
trifugation and an aliquot of the supernatant was saved (sn). Af-
ter several washes, beads were boiled in SDS sample buffer, and
corresponding supernatants (sn) and pellets (p) were assayed for
the presence of hnRNPs C1 and C2 by Western blotting with
mAb 4F4. As a reference, total HeLa nucleoplasmic extracts
were loaded (total). Antiserum Rb6 (#6) could coprecipitate
hnRNPs C1 and C2 while the corresponding preimmuneserum did
not. Coprecipitation of hnRNPs was resistant to RNase digestion
(1RNAse), indicating a physical association of Xlrbpa with these
proteins. An arrow indicates the position of hnRNPs C1 and C2.
(B) Immunoprecipitations of nuclear extracts from HeLa cells
stably expressing MP2 protein performed with anti-hnRNP anti-
body 4F4 (4F4), antiserum Rb6 (#6) or beads alone (beads). The
precipitated material (p) and corresponding supernatants (sn)
were tested for the presence of MP2 protein by Western blotting
with mAb 9E10. No MP2 protein could be coprecipitated with ei-
ther antibody, instead all MP2 protein remained in the superna-
tant. As a control total extracts of HeLa cells (total) expressing
MP2 (1) or untransfected cells (2) were loaded. An arrow indi-
cates position of MP2 protein. The strong background bands in
the 4F4 pellet lanes derive from IgG heavy and light chains,
which are detected by the secondary anti–mouse antibody used to
detect mAb 9E10.The Journal of Cell Biology, Volume 138, 1997 250
lampbrush chromosomes, and snurposomes. The nucle-
olar localization is in agreement with our finding that
Xlrbpa and TRBP are associated with ribosomes. It also
suggests that the proteins can associate with ribosomal
RNAs, possibly even nascent pre-ribosomal RNAs before
they are processed, exported to the cytoplasm, and assem-
bled into mature ribosomes.
The localization of Xlrbpa on lampbrush chromosomes
indicated an association of the protein with essentially all
nascent transcripts. Xlrbpa binds exclusively to double-
stranded RNAs in vitro (St Johnston et al., 1992; Bass et al.,
1994). This raises the question as to how the protein can
associate with the many transcripts lacking double-stranded
regions. However, the homogeneous distribution of Xlrbpa
on essentially all hnRNAs could be explained by our find-
ing that Xlrbpa is associated with hnRNP complexes. In
this case, not Xlrbpa itself but the entire hnRNP complex,
including Xlrbpa, would associate with the nascent tran-
scripts. Thus, Xlrbpa would only bind RNA when suffi-
cient double-stranded regions are available on the corre-
sponding transcript. In the absence of extensive double-
stranded structures, however, other hnRNP proteins within
the complex would bind to the RNA. The decision of which
RNA-binding protein within an hnRNP complex binds di-
rectly to RNA would thereby be governed by competition
of the proteins for a suitable binding substrate. The fact
that our control construct, MP2, fails to associate with
hnRNP particles indicates that the association of Xlrbpa
or human TRBP with hnRNPs is specific, and not caused
by the intrinsic RNA-binding ability of the two proteins.
An analogous situation has been found for the distribu-
tion of snRNPs and splicing components in amphibian
GVs. Surprisingly, all components of the splicing machin-
ery can be found on most nascent transcripts irrespective
of whether those transcripts contain suitable splice sites or
not (Wu et al., 1991). Thus, it seems as if splicing compo-
nents associate with nascent transcripts, possibly as part of
larger RNP complexes, independent of the availability of
processing sites. This situation is similar to the one found
by us, where Xlrbpa is associated with essentially all na-
scent transcripts seemingly independent of the availability
of secondary structures required for the direct binding of
the protein to RNA. Instead, Xlrbpa seems to be associ-
ated with transcripts as part of a larger hnRNP complex.
Besides an association of Xlrbpa with nucleoli and na-
scent transcripts we could find the protein in snurposomes
within the Xenopus GV. Snurposomes are spherical struc-
tures of 1–10 mm diam, which can be distinguished based
on their structure and molecular composition in B and C
snurposomes. In Xenopus, the smaller B snurposomes are
highly enriched in the five splicing snRNPs, U1, U2, U5,
and U4/U6 as well as several accessory splicing factors
(Wu et al., 1991). Additionally, staining with anti-hnRNP
antibodies indicates the presence of hnRNPs in B snurpo-
somes (Wu et al., 1991). The generally larger C snurpo-
somes, in contrast, seem to lack splicing snRNPs but con-
tain the U7 snRNP (Wu and Gall, 1993). C snurposomes
frequently have B snurposomes attached to their surface
or internalized and are thus also called sphere organelles.
These structures also contain p80 coilin, suggesting that
sphere organelles are homologous to coiled bodies found
in several somatic cells (Wu et al., 1994; Gall et al., 1995).
No hnRNPs are detectable in C snurposomes (Wu et al.,
1991). The presence of Xlrbpa in B snurposomes and its
homogeneous distribution on nascent transcripts resem-
bles that of splicing snRNPs and splicing factors, as well as
that of hnRNP proteins in the amphibian GV closely. How-
ever, in immunoprecipitations with the anti-Sm antibody,
Y12 (Lerner et al., 1981), no association of Xlrbpa with
splicing snRNPs could be detected. It is thus likely that
Xlrbpa is either present as free protein in B snurposomes
or, alternatively, associated with the other hnRNP pro-
teins found in these structures. Since Xlrbpa can be found
associated with hnRNP particles, the latter hypothesis ap-
pears more likely.
The presence of Xlrbpa in C snurposomes is more prob-
lematic. In view of the fact that anti-Sm antibodies were
unable to precipitate Xlrbpa, an association of the protein
with the U7 snRNP seems very unlikely. Also, no other
known hnRNPs could so far be detected in these or-
ganelles. Additionally, in HeLa cells we observed no indi-
cation for the presence of the Xlrbpa homologue, TRBP,
in coiled bodies, which are believed to be homologous to
sphere organelles. All these facts make a reasonable ex-
planation for the presence of Xlrbpa in C snurposomes
very difficult at this point. However, future studies will be
aimed to explain the mechanism that is responsible for the
localization of Xlrbpa in these structures.
Possible Functions of Xlrbpa
Human TRBP has been isolated by its ability to bind HIV
TAR-RNA in vitro, and has been suggested to be a human-
specific factor specifically required for the replication of
HIV in human cells (Gatignol et al., 1991). Binding speci-
ficity of TRBP for TAR-RNA has been determined by the
introduction of mutations in this RNA which abolished bind-
ing of the protein to this sequence (Gatignol et al., 1991).
However, several points argue against the notion that hu-
man TRBP is a human specific factor necessary for the rep-
lication of HIV.
First, TRBP does not seem to be exclusively present in
human cells. Our data strongly suggests that Xlrbpa is the
Xenopus homologue of TRBP, thus demonstrating the
presence of a TRBP homologue in an organism incompat-
ible with the replication of HIV.
Second, Xlrbpa and human TRBP contain three tan-
demly arranged dsRBDs. So far, no sequence-specific bind-
ing of dsRBDs could be determined in vitro. In contrast,
Xlrbpa has been isolated by its ability to bind U1 or U2
snRNAs in vitro, but can also bind poly rI/rC very effi-
ciently (St Johnston et al., 1992; Krovat and Jantsch, 1996).
Also, the third dsRBD in the Drosophila Staufen protein
binds both U1 snRNA and poly rI/rC in vitro (St Johnston
et al., 1992). None of these substrates used for in vitro assays
seem to be the natural substrates of these proteins. Thus it
is also possible that TAR-RNA is not the in vivo substrate
for human TRBP. TAR-RNA forms a stable double-
stranded hairpin region. To prove the binding specificity
of TRBP for TAR-RNA, several mutations were intro-
duced in this RNA, some of which abolished binding of
TRBP. However, all mutations affecting TRBP binding
were located in the base-paired region of the TAR-RNA
hairpin, thus destabilizing the double-stranded region (Gati-Eckmann and Jantsch Xenopus laevis Double-stranded RNA-binding Protein A 251
gnol et al., 1991). Therefore, it seems likely that structural
changes in the RNA, rather than changes in the primary
nucleic acid sequence were responsible for the observed
loss of binding of TRBP to TAR-RNA.
It has been shown that chloramphenicol transferase
(CAT)-reporter genes under the control of viral promot-
ers are more strongly expressed when TRBP was cotrans-
fected in these cells (Gatignol et al., 1991). This effect has
been proposed to be caused by a stimulation of these pro-
moters by TRBP. However, it has not been shown that
transcription from the promoter itself was increased by
TRBP. Recently, another study reported increased levels
of expression of transfected genes upon cotransfection of
either TRBP or the vaccinia virus E3L gene, another
dsRBD-containing protein (Park et al., 1994). In this case,
increased expression of the transfected genes correlated in
part with increased mRNA amounts of the corresponding
genes. Both effects, increased reporter gene activity and
increased mRNA amounts of certain transfected genes,
could be explained in part by mRNA stabilization medi-
ated by Xlrbpa or TRBP. We could show that TRBP is
part of hnRNP particles. It is thus possible that Xlrbpa or
TRBP can stabilize certain mRNAs with extensive sec-
ondary structures by binding to them.
It has also been shown that human TRBP acts as an in-
hibitor of the cellular, double-stranded–activated, inter-
feron-dependent protein kinase PKR (Park et al., 1994).
This kinase phosphorylates translation initiation factor,
eIF2a, when activated by double-stranded RNAs upon vi-
ral infection, resulting in an inhibition of translation (Kauf-
mann et al., 1989; Manche et al., 1992). Inhibition of PKR
by TRBP and other dsRBD-containing proteins has been
attributed to the masking of double-stranded RNAs, thereby
preventing binding and subsequent activation of PKR by
these substrate RNAs (Watson et al., 1991; Langland et al.,
1994; Park et al., 1994). Additionally, TRBP has been sug-
gested to be involved in the masking of cellular mRNAs
containing extensive double-stranded regions, thus pre-
cluding inadvertent activation of PKR by cellular RNAs.
This view is consistent with our finding that Xlrbpa or
TRBP associate with essentially all cellular double-stranded
RNAs. Binding of Xlrbpa or TRBP to double-stranded
RNAs might therefore help to prevent the activation of
PKR by these RNAs.
However, our finding that Xlrbpa is associated with ri-
bosomes can also be interpreted in an alternative way.
Rather than masking ribosomal RNAs to avoid activation
of PKR, Xlrbpa or TRBP might compete with the ribo-
some-associated kinase PKR for suitable substrates di-
rectly at the ribosome. Although no substrate specificities
of dsRBDs could so far be determined in vitro, biological
data suggests that dsRBD-containing proteins can bind in
a sequence-specific manner (St Johnston et al., 1991). It is
therefore possible that activation of PKR in vivo depends
on the availability of high affinity substrates for this ki-
nase. Xlrbpa would thereby act as a competitor to PKR
and prevent the binding of low affinity substrates to the ki-
nase by binding to them at the ribosome.
RNA-dependent dimerization of TRBP and PKR has
recently been demonstrated in the yeast two hybrid system
and in vitro (Cosentino et al., 1995). Direct (RNA-inde-
pendent) interaction of TRBP and PKR has also been re-
ported recently (Benkirane et al., 1997). The same study
shows that TRBP can down-regulate PKR activity in an
RNA-independent manner, possibly through direct pro-
tein–protein contact (Benkirane et al., 1997). Association
of TRBP or Xlrbpa with ribosomes could therefore be me-
diated by an association of these proteins with PKR, a ki-
nase which has also been shown to be ribosome associated
(Levin and London, 1978). However, to demonstrate RNA-
independent down-regulation of PKR by TRBP, a mutant
version of TRBP (defective in its second dsRBD and thus
unable to bind dsRNA) was used (Benkirane et al., 1997).
A similar mutation in Xlrbpa, in which the second dsRBD
has either been inactivated by mutation or completely de-
leted, still shows significant RNA-binding activity in our
hands (Krovat and Jantsch, 1996). This raises the question
of whether down-regulation of PKR by a mutated TRBP
is indeed mediated by a completely RNA-independent
mechanism or, alternatively, whether residual RNA-bind-
ing activity of the mutated TRBP might lead to the ob-
served effect, possibly by competition of TRBP for dsRNAs
that activate PKR.
Nonetheless, no PKR homologous kinase has so far
been described in Xenopus. Therefore, several other func-
tions can also be envisaged for Xlrbpa. On the one hand,
Xlrbpa might act as a general hnRNP whose main function
is the complexation and packaging of RNA. Complexation
of RNA with hnRNPs has been shown to be important for
the proper processing and export of RNA (Bennet et al.,
1992; Mayeda and Krainer, 1992; Piñol-Roma and Drey-
fuss, 1993). At the same time, hnRNPs might stabilize and
protect RNA from degradation. On the other hand, Xlrbpa
might itself influence the folding state of RNA. Since
Xlrbpa binds exclusively to double-stranded regions it
might either help in the formation of such structured re-
gions, stabilize such regions or, alternatively, destabilize
double-stranded regions. Double-strand annealing and un-
winding activities have also been reported for other RNA-
binding proteins (Cobianchi et al., 1993; Portman and
Dreyfuss, 1994; Xiao et al., 1994). The structure of two
dsRBDs from different proteins has recently been solved
and showed a conserved structure for those two dsRBDs
(Bycroft et al., 1995; Kharrat et al., 1995). Mutational anal-
yses of Xlrbpa suggest that the dsRBDs found in Xlrbpa
assume the same conserved tertiary structure (Krovat and
Jantsch, 1996). However, little is known about the way
double-stranded RNA-binding domains interact with RNA
which makes an assessment about other functions of Xlrbpa
purely speculative at this point. Nonetheless, studies to deter-
mine the mode of interaction of dsRBDs with RNA are un-
der way and will hopefully help to shed some light on these
unsolved questions. It will also be interesting to determine
whether Xlrbpa and its human counterpart, TRBP, play a
role in mRNA turnover and translation of cellular RNAs.
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